Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > 33-year analysis highlights earlier keratoconus diagnosis and advanced treatment trends
  • Cornea and External Disease

33-year analysis highlights earlier keratoconus diagnosis and advanced treatment trends

Kelsey Moroz

Over the past 33 years, advancements in diagnostic methods and treatment options have led to earlier detection and improved management of keratoconus, resulting in increased use of contact lenses and collagen crosslinking (CXL), reducing the need for invasive keratoplasty surgeries, with a shift towards less invasive procedures like deep anterior lamellar keratoplasty (DALK), according to a study.

The study analyzed data from 20,576 patients diagnosed with KC in at least 1 eye between 1987 and 2020.

There was a significant decrease in the mean age at diagnosis of keratoconus, from 29.3 years (1987-1991) to 22.2 years (2016-2020), indicating earlier detection over time. Adults comprised 76.64% of cases, with a male predominance of 61.25%. The use of contact lenses among patients increased from 4.34% (2002-2006) to 11.23% (2016-2020). Collagen crosslinking (CXL) treatment became more common, rising from 22.28% (2007-2011) to 53.61% (2012-2016) and 72.53% (2017-2020). In addition, advancements in surgery led to more patients choosing DALK over traditional penetrating keratoplasty. In the last 8 years, 17.2% of patients had surgery, with CXL being the most frequent (14.77%), followed by DALK (1.72%), and penetrating keratoplasty (1.04%).

Reference
Deshmukh RS, Das AV, Vaddavalli PK. Evolving Trends in the Diagnosis and Management of Keratoconus Over 3 Decades. Cornea. 2024;doi: 10.1097/ICO.0000000000003635. Epub ahead of print. PMID: 39012335.

Share

Related Content

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

  • Conference Roundup

New screening device for keratoconus may help identify patients earlier

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon